Tat-SF1 protein associates with RAP30 and human SPT5 proteins

Molecular and Cellular Biology

Volumn 19, Issue 9, 1999, Pages 5960-5968

  Kim, Jae B ^a   Yamaguchi, Yuki ^b   Wada, Tadashi ^b   Handa, Hiroshi ^b   Sharp, Phillip A ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RNA POLYMERASE; TRANSACTIVATOR PROTEIN;

ARTICLE; COMPLEX FORMATION; ENZYME ANALYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

EID: 0032792831     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.9.5960     Document Type: Article

References (45)

1. Bieniasz, P. D., T. A. Gardina, H. P. Bogerd, and B. R. Cullen. 1998. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J. 17:7056-7065.
2. Buratowski, S., S. Hahn, P. A. Sharp, and L. Guarente. 1988. Function of a yeast TATA element-binding protein in a mammalian transcription system. Nature 334:37-42.
3. Chen, D., Y. Fong, and Q. Zhou. 1999. Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription. Proc. Natl. Acad. Sci. USA 96:2728-2733.
4. Cujec, T., H. Okamoto, K. Fujinaga, J. Meyer, H. Chamberlin, D. O. Morgan, and B. M. Peterlin. 1997. The HIV transactivator Tat binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev. 11:2545-2657.
5. Cullen, B. R. 1993. Does HIV-1 Tat induce a change in viral initiation rights? Cell 73:417-420.
6. Cullen, B. R. 1998. HIV-1 auxiliary proteins: making connections in a dying cell. Cell 93:685-692.
7. Emerman, M., and M. H. Malim. 1998. HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. Science 280:1880-1884.
8. Feng, S., and E. C. Holland. 1988. HIV-1 tat trans-activation requires the loop sequence within tar. Nature 334:165-167.
9. Garber, M. E., P. Wei, V. N. KewalRamani, T. P. Mayall, C. H. Herrmann, A. P. Rice, D. R. Littman, and K. A. Jones. 1998. The interaction between HIV-1 tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12:3512-3527.
10. Garcia-Martinez, L. F., G. Mavankal, J. M. Neveu, W. S. Lane, D. Ivanov, and R. B. Gaynor. 1997. Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J. 16:2836-2850.
11. Hartzog, G. A., T. Wada, H. Handa, and F. Winston. 1998. Evidence that SPT4, SPT5 and SPT6 control transcription elongation by RNA polymerase II in Saccharomyces cerevisiae. Genes Dev. 12:357-369.
12. Herrmann, C. H., and A. P. Rice. 1993. Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology 197:601-608.
13. Herrmann, C. H., and A. P. Rice. 1995. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol. 69:1612-1620.
14. Holstege, F. C. P., and R. A. Young. 1999. Transcriptional regulation: contending with complexity. Proc. Natl. Acad. Sci. USA 96:2-4.
15. Jones, K. A. 1997. Taking a new TAK on tat transactivation. Genes Dev. 11:2593-2599.
16. Jones, K. A., and B. M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717-743.
17. Kato, H., H. Sumimoto, P. Pognonec, C. H. Chen, C. A. Rosen, and R. G. Roeder. 1992. HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. Genes Dev. 6:655-666.
18. Li, X. Y., and M. R. Green. 1998. The HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factor. Genes Dev. 12:2992-2996.
19. Mancebo, H. S., G. Lee, J. Flygare, J. Tomassini, P. Luu, Y. Zhu, J. Peng, C. Blau, D. Hazuda, D. Price, and O. Flores. 1997. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11:2633-2644.
20. Marciniak, R. A., B. J. Calnan, A. D. Frankel, and P. A. Sharp. 1990 HIV-1 Tat protein trans-activates transcription in vitro. Cell 63:791-802.
21. Marciniak, R. A., and P. A. Sharp. 1991. HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J. 10:4189-4196.
22. Marshall, N. F., J. Peng, Z. Xie, and D. H. Price. 1996. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal kinase. J. Biol. Chem. 271:27176-27183.
23. Marshall, N. F., and D. H. Price. 1995. Purification of P-TEFb, a transcription factor required for the transition info productive elongation. J. Biol. Chem. 270:12335-12338.
24. Parada, C. A., and R. G. Roeder. 1996. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature 384:375-378.
25. Parvin, J. D., B. M. Shykind, R. E. Meyers, J. Kim, and P. A. Sharp. 1994. Multiple sets of basal factors initiate transcription by RNA polymerase II. J. Biol. Chem. 269:18414-18421.
26. Peng, J., Y. Zhu, J. T. Milton, and D. H. Price. 1998. Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 12:755-762.
27. Ratnasabapathy, R., M. Sheldon, L. Johal, and N. Hernandez. 1990. The HIV-1 long terminal repeat contains an unusual element that induces the synthesis of short RNAs from various mRNA and snRNA promoters. Genes Dev. 4:2061-2074.
28. Sehgal, P. B., J. E. Darnell, and I. Tamm. 1976. The inhibition by DRB(5,6-dichloro-1-β-D-ribofuranosylbenzimidazole) of hnRNA and mRNA production in HeLa cells. Cell 9:473-480.
29. Tan, S., T. Aso, R. C. Conaway, and J. W. Conaway. 1994. Roles for both the RAP30 and RAP74 subunits of transcription factor IIF in transcription initiation and elongation by RNA polymerase II. J. Biol. Chem. 269:25684-25691.
30. Tan, S., R. C. Conaway, and J. W. Conaway. 1995. Dissection of transcription factor TFIIF functional domains required for initiation and elongation. Proc. Natl. Acad. Sci. USA 92:6042-6046.
31. Wada, T., T. Takagi, Y. Yamaguchi, A. Ferdous, T. Imai, S. Hirose, S. Sugimoto, K. Yank, G. A. Hartzog, F. Winston, S. Buratowski, and H. Handa. 1998. DSIF, a novel transcription elongation factor that regulate RNA polymerase II processivity, is composed of human SPT4 and SPT5 homologs. Genes Dev. 12:343-353.
32. Wada, T., T. Takagi, Y. Yamaguchi, D. Watenabe, and H. Handa. 1998. Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. EMBO J. 17:7395-7403.
33. Wel, P., M. E. Garber, S. M. Fang, W. H. Fischer, and K. A. Jones. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451-462.
34. Winston, F., and M. Carlson. 1992. Yeast Snf/Swi transcriptional activators and Spt/Sin chromosome connection. Trends Genet. 8:387-391.
35. Wu-Baer, F., W. S. Lane, and R. B. Gaynor. 1998. Role of the human homolog of the yeast transcription factor SPT5 in HIV-1 Tat-activation. J. Mol. Biol. 277:179-197.
36. Yamaguchi, Y., T. Takagi, T. Wada, K. Yano, A. Furuya, S. Sugimoto, T. Hasegawa, and H. Handa. 1999. NELF, amultisubunit complex containing RD, cooperates with DSIF to repress RNA potymerase II elongation. Cell 97:41-51.
37. Yamaguchi, Y., T. Wada, and H. Handa. 1998. Interplay between positive and negative elongation factors: drawing a new view of DRB. Genes Cells 3:9-15.
38. Yamaguchi, Y., T. Wada, D. Watanabe, T. Takagi, J. Hasegawa, and H. Handa. 1999. Structure and function of the human transcription elongation factor DSIF. J. Biol. Chem. 274:8085-8092.
39. Yang, X., C. H. Herrmann, and A. P. Rice. 1996. The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function. J. Virol. 70:4576-4584.
40. Yankulov, K., K. Yamashita, R. Roy, J. M. Egly, and D. L. Bently. 1995. The transcriptional elongation inhibitor 5,6-dichloro-1-β-D-ribofuransyl benzimidazole inhibits transcription factor TFIIH associated protein kinase. J. Biol. Chem. 270:23922-23925.
41. Zawel, L., K. P. Kumar, and D. Reinberg. 1995. Recycling of the general transcription factors during RNA polymerase II transcription. Genes Dev. 9:1479-1490.
42. Zhou, Q., D. Chen, E. Plerstorft, and K. Luo. 1998. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J. 17:3681-3691.
43. Zhou, Q., and P. A. Sharp. 1995. Novel mechanism and factor for regulation by HIV-1 Tat. EMBO J. 14:321-328.
44. Zhou, Q., and P. A. Sharp. 1996. Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat. Science 274:605-610.
45. Zhu, Y., T. Pe'ery, J. Peng, Y. Ramanathan, N. Marshall, T. Marshall, B. Amendt, M. B. Mathews, and D. H. Price. 1997. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 11:2622-2632.